Environmental Science and Pollution Research

, Volume 26, Issue 19, pp 19684–19696 | Cite as

Photo-oxidative degradation of doxorubicin with siloxane MOFs by exposure to daylight

  • Carmen RaclesEmail author
  • Mirela-Fernanda Zaltariov
  • Mihaela Silion
  • Ana-Maria Macsim
  • Vasile Cozan
Research Article


Doxorubicin (DOX) is a chemotherapeutic agent from anthracycline class, which acts unselectively on all cells; thus, it may have genotoxic and/or mutagenic effects and cause serious environmental problems. Herein, the decomposition of a diluted solution of DOX hydrochloride for injection has been investigated under photo-oxidative conditions, in ambient light and without pH modification, using hydrogen peroxide as oxidizing agent and hydrophobic siloxane-based metal-organic frameworks (MOFs) as heterogeneous catalysts. The kinetics of the photodegradation process was followed by UV-Vis spectroscopy and by ESI-MS. According to UV-Vis data, two pseudo-first-order kinetic steps describe the process, with rate constants in the order of 10−3–10−2 min−1 for the rate-determining one. ESI-MS provided more accurate information, with a rate constant of 2.6 · 10−2 min−1 calculated from the variation of DOX ion abundance. Complete decomposition of DOX was achieved after 120 min in the shade and after only 20 min by exposure to sunlight. The analysis of the residual waters by mass spectrometry and 1D and 2D NMR spectroscopy showed complete disappearance of DOX in all cases, excluded any anthracycline species, which are destroyed in the tested conditions, and proved formation of an un-harmful compound—glycerol, while no trace of metal was detected by XRF. Preliminary data also showed decomposition of oxytetracycline in similar conditions. By this study, we bring into attention a less-addressed pollution issue and we propose a mild and effective method for the removal of drug emerging pollutants.


Photodecomposition Heterogeneous catalyst Siloxane MOF Doxorubicin Hydrogen peroxide Anthracycline degradation 


Funding information

This work was supported by a grant of Romanian Ministry of Research and Innovation, CNCS - UEFISCDI, project number PN-III-P4-ID-PCCF-2016-0050 (5D-nanoP), within PNCDI III.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

11356_2019_5288_MOESM1_ESM.doc (3.1 mb)
ESM 1 (DOC 3143 kb)


  1. Abraham SA, Waterhouse DN, Mayer LD, Cullis PR, Madden TD, Bally MB (2005) The liposomal formulation of doxorubicin. Methods Enzymol 391:71–97. CrossRefGoogle Scholar
  2. Beijnen JH, van der Houwen OAGJ, Underberg WJM (1986) Aspects of the degradation kinetics of doxorubicin in aqueous solution. Int J Pharm 32:123–131. CrossRefGoogle Scholar
  3. Bokare AD, Choi W (2014) Review of iron-free Fenton-like systems for activating H2O2 in advanced oxidation processes. J Hazard Mater 275:121–135. CrossRefGoogle Scholar
  4. Chartier Y, Emmanuel J, Pieper U, Pruss A, Rushbrook P, Stringer R, Townend W, Wilbum S., Zghondi R (Eds.) (2014) Safe management of wastes from health-care activities. Second ed. (World Health Organization)Google Scholar
  5. Cho H, Lai TC, Tomoda K, Kwon GS (2015) Polymeric micelles for multi-drug delivery in cancer. AAPS PharmSciTech 16:10–20. CrossRefGoogle Scholar
  6. Chudasama V, Maruani A, Caddick S (2016) Recent advances in the construction of antibody–drug conjugates. Nat Chem 8:114–119. CrossRefGoogle Scholar
  7. Cvrčková O, Ciganek M (2005) Photostability of polycyclic aromatic hydrocarbons (PAHs) and nitrated polycyclic aromatic hydrocarbons (NPAHs) in dichloromethane and isooctane solutions. Polycycl Aromat Compd 25:141–156. CrossRefGoogle Scholar
  8. Das A, Adhikari C, Nayak D, Chakraborty A (2016) First evidence of the liposome-mediated deintercalation of anticancer drug doxorubicin from the drug−DNA complex: a spectroscopic approach. Langmuir 32:159–170. CrossRefGoogle Scholar
  9. Dhakshinamoorthy A, Li Z, Garcia H (2018) Catalysis and photocatalysis by metal organic frameworks. Chem Soc Rev 47:8134–8172. CrossRefGoogle Scholar
  10. Dong DW, Tong SW, Qi XR (2013) Comparative studies of polyethylenimine–doxorubicin conjugates with pH-sensitive and pH-insensitive linkers. J Biomed Mater Res A 101A:1336–1344. CrossRefGoogle Scholar
  11. Dumitru R, Ianculescu A, Păcurariu C, Lupa L, Pop A, Vasile B, Surdu A, Manea F (2019) BiFeO3 - synthesis, characterization and its photocatalytic activity towards doxorubicin degradation from water. Ceram Int 45:2789–2802. CrossRefGoogle Scholar
  12. González B, Trujillano R, Vicente MA, Rives V, Korili SA, Gil A (2019) Photocatalytic degradation of trimethoprim on doped Ti-pillared montmorillonite. Appl Clay Sci 167:43–49. CrossRefGoogle Scholar
  13. Hansel S, Castegnaro M, Sportouch MH, De Méo M, Milhavet JC, Laget M, Duménil G (1997) Chemical degradation of wastes of antineoplastic agents: cyclophosphamide, ifosfamide and melphalan. Int Arch Occup Environ Health 69:109–114. CrossRefGoogle Scholar
  14. Kadu BS, Wani KD, Kaul-Ghanekar R, Chikate RC (2017) Degradation of doxorubicin to non-toxic metabolites using Fe-Ni bimetallic nanoparticles. Chem Eng J 325:715–724. CrossRefGoogle Scholar
  15. Kaushik D, Bansal G (2015) Four new degradation products of doxorubicin: an application of forced degradation study and hyphenated chromatographic techniques. J Pharma Anal 5:285–295. CrossRefGoogle Scholar
  16. Khosravi A, Mokhtari J, Naimi-Jamal MR, Tahmasebi S, Panahi L (2017) Cu2(BDC)2(BPY)–MOF: an efficient and reusable heterogeneous catalyst for the aerobic Chan–Lam coupling prepared via ball-milling strategy. RSC Adv 7:46022–46027. CrossRefGoogle Scholar
  17. Kosjek T, Heath E (2011) Occurrence, fate and determination of cytostatic pharmaceuticals in the environment. Trends Anal Chem 30:1065–1087. CrossRefGoogle Scholar
  18. Larkin P (2011) Infrared and Raman spectroscopy. Principles and spectral interpretation. Elsevier, AmsterdamGoogle Scholar
  19. Le Bot MA, Riche C, Guedes Y, Kernaleguen D, Simon S, Begue JM, Berthou F (1987) Study of doxorubicin photodegradation in plasma, urine and cell culture medium by HPLC. Biomed Chromatogr 2:242–244. CrossRefGoogle Scholar
  20. Le HTN, Tran TV, Phan NTS, Truong T (2015) Efficient and recyclable Cu2(BDC)2(BPY)-catalyzed oxidative amidation of terminal alkynes: role of bipyridine ligand. Catal Sci Technol 5:851–859. CrossRefGoogle Scholar
  21. Lee SG, Tkaczuk M, Jankewicz G, Ambados F (2007) Surface contamination from cytotoxic chemotherapy following preparation and administration. J Pharm Pract Res 37:271–276. CrossRefGoogle Scholar
  22. Matsumoto K, Naito T, Hori K, Suzuki N, Miyamoto Y, Takashina Y, Ohnishi K, Kawakami J (2010) Surveillance of workplace contamination and occupational exposure to antineoplastic agents in a hospital setting: establishment of a monitoring method using doxorubicin. Yakugaku Zasshi J 130:431–439CrossRefGoogle Scholar
  23. Ming Y, Purewal J, Yang J, Xu C, Soltis R, Warner J, Veenstra M, Gaab M, Müller U, Siegel DJ (2015) Kinetic Stability of MOF-5 in Humid Environments: Impact of Powder Densification, Humidity Level, andExposure Time. Langmuir 31:4988–4995.
  24. Mordente A, Meucci E, Silvestrini A, Martorana GE, Giardina B (2009) New developments in anthracycline-induced cardiotoxicity. Curr Med Chem 16:1656–1672. CrossRefGoogle Scholar
  25. Nawara K, Krysinski P, Blanchard GJ (2012) Photoinduced reactivity of doxorubicin: catalysis and degradation. J Phys Chem A 116:4330–4337. CrossRefGoogle Scholar
  26. Niu S, Zhang R, Zhou X, Zhao X, Suo H, Jiao Y, Yao H, Guo C (2018) The enhanced photocatalytic activity of Yb3+-Ho3+/Er3+ co-doped 3D BiOCl flower. Dyes and Pigments 149:462–469. CrossRefGoogle Scholar
  27. Phan NTS, Nguyen TT, Vu PHL (2013) A copper metal–organic framework as an efficient and recyclable catalyst for the oxidative cross-dehydrogenative coupling of phenols and formamides. ChemCatChem 5:3068–3077. CrossRefGoogle Scholar
  28. Pi Y, Li X, Xia Q, Wu J, Li Y, Xiao J, Li Z (2018) Adsorptive and photocatalytic removal of persistent organic pollutants (POPs) in water by metal-organic frameworks (MOFs). Chem Eng J 337:351–371. CrossRefGoogle Scholar
  29. Piorecka K, Stanczyk W, Florczak M (2017) NMR analysis of antitumor drugs: doxorubicin, daunorubicin and their functionalized derivatives. Tetrahedron Lett 58:152–155. CrossRefGoogle Scholar
  30. Racles C, Shova S, Cazacu M, Timpu D (2013) New highly ordered hydrophobic siloxane-based coordination polymers. Polymer 54:6096–6104. CrossRefGoogle Scholar
  31. Racles C, Zaltariov MF, Iacob M, Silion M, Avadanei M, Bargan A (2017) Siloxane-based metal–organic frameworks with remarkable catalytic activity in mild environmental photodegradation of azo dyes. Appl Catal B 205:78–92. CrossRefGoogle Scholar
  32. Rafiyath SM, Rasul M, Lee B, Wei G, Lamba G, Liu D (2012) Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis. Exp Hematol Oncol 1:10 Available at [verified 27 December 2018]CrossRefGoogle Scholar
  33. Ramphal R, Bains T, Goulet G, Vaillancourt R (2015) Occupational exposure to chemotherapy of pharmacy personnel at a single centre. Can J Hosp Pharm 68:104–112Google Scholar
  34. Ramu A, Mehta MM, Liu J, Turyan I, Aleksic A (2000) The riboflavin-mediated photooxidation of doxorubicin. Cancer Chemother Pharmacol 46:449–458. CrossRefGoogle Scholar
  35. Raniolo S, Vindigni G, Ottaviani A, Unida V, Iacovelli F, Manetto A, Figini M, Stella L, Desideri A, Biocca S (2018) Selective targeting and degradation of doxorubicin-loaded folate-functionalized DNA nanocages. Nanomedicine 14:1181–1190. CrossRefGoogle Scholar
  36. Revia RA, Zhang M (2016) Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances. Mater Today 19:157–168. CrossRefGoogle Scholar
  37. Şentürk N, Top A (2018) PEG-peptide conjugate containing cathepsin B degradation unit as a doxorubicin carrier system. Turk J Chem 42:385–400. Google Scholar
  38. Somensi CA, Simionatto EL, Dalmarco JB, Gaspareto P, Radetski CM (2012) A comparison between ozonolysis and sonolysis/ozonolysis treatments for the degradation of the cytostatic drugs methotrexate and doxorubicin: kinetic and efficiency approaches. J Environ Sci Health A 47:1543–1550. CrossRefGoogle Scholar
  39. Sun C, Li Y, Song P, Ma F (2016) An experimental and theoretical investigation of the electronic structures and photoelectrical properties of ethyl red and carminic acid for DSSC application. Materials 9(22 pp):813. CrossRefGoogle Scholar
  40. Sun K, Li L, Yu XL, Liu L, Meng Q, Wang F, Zhang R (2017) Functionalization of mixed ligand metal-organic frameworks as the transport vehicles for drugs. J Colloid Interface Sci 486:128–135. CrossRefGoogle Scholar
  41. Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65:157–170. CrossRefGoogle Scholar
  42. Tavoloni N, Guarino AM, Berk PD (1980) Photolytic degradation of Adriamycin. J Pharm Pharmacol 32:860–862. CrossRefGoogle Scholar
  43. Thongrasmee W, Tohsing K, Janjai S (2018) A model for calculating daily near infrared solar radiation. J Phys Conf Ser 1144:012040. CrossRefGoogle Scholar
  44. Vasconcelos IB, da Silva TG, Militão GCG, Soares TA, Rodrigues NM, Rodrigues MO, da Costa Jr. NB, Freiree RO, Junior SA (2012) Cytotoxicity and slow release of the anti-cancer drug doxorubicin from ZIF-8. RSC Adv 2:9437–9442.
  45. Wang CC, Li JR, Lv XL, Zhang YQ, Guo G (2014) Photocatalytic organic pollutants degradation in metal–organic frameworks. Energy Environ Sci 7:2831–2867. CrossRefGoogle Scholar
  46. Wood MJ, Irwin WJ, Scott DK (1990) Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high performance liquid chromatography. J Clin Pharm Ther 15:291–300. CrossRefGoogle Scholar
  47. World Health Organization (2018) Cancer fact sheet, Available at
  48. Wu JCS, Chen CH (2004) A visible-light response vanadium-doped titania nanocatalyst by sol–gel method. J Photochem Photobiol A Chem 163:509–515. CrossRefGoogle Scholar
  49. Yang Y, Yin LC, Gong Y, Niu P, Wang JQ, Gu L, Chen X, Liu G, Wang L, Cheng HM (2018) An unusual strong visible-light absorption band in red anatase TiO2 photocatalyst induced by atomic hydrogen-occupied oxygen vacancies. Adv Mater 1704479(8pp).
  50. Zhang KL, Liu CM, Huang FQ, Zheng C, Wang WD (2006) Study of the electronic structure and photocatalytic activity of the BiOCl photocatalyst. Appl Catal B-Environ 68:125–129. CrossRefGoogle Scholar
  51. Zhang H, Jiang W, Liu R, Zhang J, Zhang D, Li Z, Luan Y (2017) Rational design of MOF nanocarrier-based co-delivery system of doxorubicin hydrochloride/verapamil hydrochloride for overcoming multidrug resistance with efficient targeted cancer therapy. ACS Appl Mater Interfaces 9:19687–19697.
  52. Ming Y, Purewal J, Yang J, Xu C, Soltis R, Warner J, Veenstra M, Gaab M, Müller U, Siegel DJ (2015) Kinetic stability of MOF-5 in humid environments: impact of powder densification, humidity level, and exposure time. Langmuir 31 (17):4988-4995Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Inorganic Polymers“Petru Poni” Institute of Macromolecular ChemistryIasiRomania
  2. 2.Advanced Research Centre for Bionanoconjugates and Biopolymers“Petru Poni” Institute of Macromolecular ChemistryIasiRomania
  3. 3.NMR Department“Petru Poni” Institute of Macromolecular ChemistryIasiRomania
  4. 4.Department of Polycondensation and Thermostable Polymers“Petru Poni” Institute of Macromolecular ChemistryIasiRomania

Personalised recommendations